MADEDDU, GIORDANO
 Distribuzione geografica
Continente #
NA - Nord America 110
EU - Europa 65
AS - Asia 55
SA - Sud America 13
AF - Africa 1
OC - Oceania 1
Totale 245
Nazione #
US - Stati Uniti d'America 109
IT - Italia 56
SG - Singapore 51
BR - Brasile 13
HK - Hong Kong 4
DE - Germania 3
NL - Olanda 3
IE - Irlanda 2
AU - Australia 1
CI - Costa d'Avorio 1
FI - Finlandia 1
MX - Messico 1
Totale 245
Città #
Santa Clara 84
Singapore 43
Rende 12
Catania 10
Bologna 4
Hong Kong 4
Misterbianco 4
New York 4
Bastiglia 3
Rome 3
Boardman 2
Chicago 2
Dublin 2
Gütersloh 2
Los Angeles 2
Messina 2
Milan 2
San Giovanni la Punta 2
Siena 2
São Paulo 2
Abidjan 1
Arcoverde 1
Belo Horizonte 1
Castanhal 1
Conceição do Coité 1
Florence 1
Guadalajara 1
Ipirá 1
Iporá 1
Joinville 1
Karlsruhe 1
Lappeenranta 1
Nova Friburgo 1
Palermo 1
Porto Alegre 1
Recife 1
Sydney 1
Trento 1
Vitória 1
Totale 210
Nome #
Assessing ChatGPT’s theoretical knowledge and prescriptive accuracy in bacterial infections: a comparative study with infectious diseases residents and specialists 55
Virological response and retention in care according to time of starting ART in Italy: Data from the Icona Foundation Study cohort 28
Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: results a large multicentre observational prospective cohort (SCOLTA) 21
Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy 19
Weight gain: A possible side effect of all antiretrovirals 15
Treatment simplification to atazanavir/ritonavir+lamivudine versus maintenance of atazanavir/ritonavir+two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M) 14
Enhanced immunological recovery with early start of antiretroviral therapy during acute or early HIV infection–results of Italian network of acute HIV infection (Inaction) retrospective study 13
Safety and tolerability of Elvitegravir/ Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project 13
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA project 12
Discontinuation of treatment and adverse events in an Italian cohort of patients on dolutegravir 11
Factors associated with weight gain in people treated with dolutegravir 11
Impact of genotypic susceptibility score on cART outcomes during primary HIV infection 10
Viro-Immunological Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide among Women Living with HIV: A 96-Week Post-Switch Analysis from the Real-Life SHiNe-SHiC Cohort 9
Predictors of incomplete viral response and virologic failure in patients with acute and early HIV infection. Results of Italian Network of ACuTe HIV InfectiON (INACTION) cohort 4
Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: Results from a large observational cohort study (SCOLTA) 4
Novelties in evaluation and monitoring of human immunodeficiency virus-1 infection: Is standard virological suppression enough for measuring antiretroviral treatment success? 4
Safety and durability in a cohort of HIV-1 positive patients treated with once and twice daily darunavir-based therapy (SCOLTA Project) 4
Lipid profile improvement in virologically suppressed hiv-1-infected patients switched to dolutegravir/ abacavir/lamivudine: Data from the SCOLTA project 4
Raltegravir-based therapy in a cohort of HIV/HCV co-infected individuals 4
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 4
Muscle symptoms and creatine phosphokinase elevations in patients receiving raltegravir in clinical practice: Results from the SCOLTA project long-term surveillance 3
Symmetric ambulatory arterial stiffness index and 24-h pulse pressure in HIV infection: Results of a nationwide cross-sectional study 3
Efficacy of 1998 Vs 2006 first-line antiretroviral regimens for HIV infection: An ordinary clinics retrospective investigation 3
Time trend in hypertension prevalence, awareness, treatment, and control in a contemporary cohort of HIV-infected patients: The HIVand Hypertension Study 2
Totale 270
Categoria #
all - tutte 1.503
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.503


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20233 0 0 0 0 0 0 0 0 3 0 0 0
2023/20242 0 0 0 0 0 1 0 0 0 0 0 1
2024/2025265 8 7 7 7 93 49 3 12 34 41 4 0
Totale 270